Clinical trials for PAD are research studies designed to evaluate new treatments, medications, or procedures aimed at improving outcomes for individuals with PAD.
Peripheral artery disease clinical trials, where your involvement will contribute to better health outcomes.
Peripheral Artery Disease (PAD) is a circulatory condition characterized by narrowed arteries that reduce blood flow to the limbs, usually the legs.
Left untreated, PAD can lead to serious complications such as non-healing wounds, tissue damage, and even amputation.
Hightower is currently conducting an observational peripheral artery disease clinical trial.
*Participation in the Clinical Trial is completely free of cost and is your choice.
*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.
Peripheral artery disease (PAD) is atherosclerosis, a condition where fatty deposits, called plaques, build up inside the arteries, causing them to become narrow and hardened. Over time, this restricts blood flow to the affected areas. Throughout the trial, qualified healthcare professionals will provide you with comprehensive care related to the study.
*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.
*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.
If you decide to participate in the peripheral artery disease clinical trials, you must fill out the form above. Someone from the study team will contact you to determine your eligibility. The study doctors will review the details with you to see if you meet the eligibility criteria for the peripheral thrombosis clinical trials.
You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for peripheral artery disease and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form.
*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.
18 years and above
Male & Female
Atrial Fibrillation
Recruiting
Peripheral artery disease (PAD) is a condition that affects blood flow in the arteries, particularly those leading to the legs and feet. It occurs when fatty deposits, known as plaque, build up inside the arteries, narrowing the passage and restricting blood flow. This reduced blood flow can cause pain, cramping, and even tissue death in severe cases.
Clinical trials for PAD are research studies designed to evaluate new treatments, medications, or procedures aimed at improving outcomes for individuals with PAD.
Participants in clinical trials for PAD may have access to treatments or procedures before they are widely available. Additionally, they may receive close monitoring and care from experienced healthcare professionals.
Yes, participation in a clinical trial for PAD is entirely voluntary. Participants have the right to decide whether or not to participate and can withdraw from the study at any time without penalty.